Nulife Advanced Diagnostics Private Limited

Nulife Advanced Diagnostics Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
CIN U85300DL2022PTC403313 Incorporated 18 August 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹97.21 Lakh
Latest filing
Net loss · FY 2025
₹1.69 Cr
Net margin -174.1%
EBITDA · FY 2025
₹15.99 Lakh
EBITDA margin 16.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.51 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings

About Nulife Advanced Diagnostics Private Limited

Data last updated:

Nulife Advanced Diagnostics Private Limited is a private limited company based in Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 18 August 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85300DL2022PTC403313.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Javinder Singh and Akshay Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 1616 First Floor Outram Line Gtb Nagar, Delhi, India – 110009.

As per the financials filed for FY 2025, the company reported a revenue of ₹97.21 Lakh. For the same year it recorded a net loss of ₹1.69 Cr (net margin -174.1%) and EBITDA of ₹15.99 Lakh (EBITDA margin 16.4%).

As per MCA filings, the company has open charges of ₹5.51 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85300DL2022PTC403313
Registration Number 403313
Incorporation Date 18 August 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Nulife Advanced Diagnostics Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    House No. 1616 First Floor Outram Line Gtb Nagar, Delhi, India – 110009
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Nulife Advanced Diagnostics Private Limited, buy the company report.

Comprehensive company report
Nulife Advanced Diagnostics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Nulife Advanced Diagnostics Private Limited

FY 2025 filings available

Nulife Advanced Diagnostics Private Limited reported revenue of ₹97.21 Lakh for FY 2025.

Revenue · FY 2025
₹97.21 Lakh
Net loss · FY 2025
₹1.69 Cr margin -174.1%
EBITDA · FY 2025
₹15.99 Lakh margin 16.4%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.99 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.69 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin16.4%
Net Profit Margin-174.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nulife Advanced Diagnostics Private Limited, buy the company report.

Board of directors of Nulife Advanced Diagnostics Private Limited

Nulife Advanced Diagnostics has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Javinder SinghDirector18 Aug 20224 Years 2 MonthsCurrent
Akshay KumarDirector18 Aug 20224 Years 2 MonthsCurrent
Babita GuptaDirector13 Sep 20224 Years 1 MonthsCurrent

Peer comparison

Nulife Advanced Diagnostics Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Viva Laboratories Pvt Ltd₹97.43 Lakh (FY 2022)-66.0%Ahmedabad, Gujarat, India
Orbiscan and Diagnostics Private Limited₹97.35 Lakh (FY 2025)11.0%Hari Nagar, Delhi, India
Samyak Daignostic Private Limited₹97.29 Lakh (FY 2025)1.0%Mumbai, Maharashtra, India
Nulife Advanced Diagnostics Private Limitedthis company₹97.21 Lakh (FY 2025)-₹1.69 Cr-174.1%Delhi, India
Arica Diagnostic Private Limited₹96.92 Lakh (FY 2025)14.0%Kolkata, West Bengal, India
Kunal Institue of Medical Specialities Private Limited₹96.31 Lakh (FY 2025)8.0%Hyderabad, Telangana, India
Qualitify Healthtech Private Limited₹96.15 Lakh (FY 2025)Bangalore, Karnataka, India

To see the full peer comparison of Nulife Advanced Diagnostics Private Limited, buy the company report.

Auditor

Nulife Advanced Diagnostics Private Limited is audited by K.P THAPAR & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K.P THAPAR & COFY 2023501995

Shareholding

The shareholding of Nulife Advanced Diagnostics Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nulife Advanced Diagnostics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.51 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.51 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Oct 2023100798147Others₹5.51 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nulife Advanced Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Nulife Advanced Diagnostics Private Limited has 1 active EPFO establishment as of Apr 05, 2024.

Active EPFO establishments
1

GST

No GST registration is on our record for Nulife Advanced Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Nulife Advanced Diagnostics Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Babita Gupta was appointed as Director on 13 Sep 2022.

AGM
Nulife Advanced Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nulife Advanced Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 551.00 Lakh with Charge ID 100798147 was registered on 06 Oct 2023.
Appointed
Babita Gupta was appointed as Director.
Appointed
Akshay Kumar was appointed as Director.
Appointed
Javinder Singh was appointed as Director.
Incorporation
18 Aug 2022
Nulife Advanced Diagnostics Private Limited was registered on 18 Aug 2022 with Roc Delhi Ii & aged 4 years 2 months as per MCA records.

Frequently asked questions

Nulife Advanced Diagnostics is an active private limited company based in Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 18 August 2022 (4+ years old) and is registered under CIN U85300DL2022PTC403313.

Nulife Advanced Diagnostics has 3 current directors:

The latest financial statements of Nulife Advanced Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Nulife Advanced Diagnostics is U85300DL2022PTC403313. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nulife Advanced Diagnostics was incorporated on 18 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Nulife Advanced Diagnostics by revenue are Viva Laboratories Pvt Ltd, Orbiscan and Diagnostics Private Limited, Samyak Daignostic Private Limited, Arica Diagnostic Private Limited, Kunal Institue of Medical Specialities Private Limited and 1 more, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).

Babita Gupta was appointed as Director on 13 Sep 2022. Akshay Kumar was appointed as Director on 18 Aug 2022. Javinder Singh was appointed as Director on 18 Aug 2022.

The registered office of Nulife Advanced Diagnostics is at House No. 1616 First Floor Outram Line Gtb Nagar, Delhi, India – 110009.

Nulife Advanced Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.

Nulife Advanced Diagnostics has open charges of ₹5.51 Cr and no satisfied charges on record as per latest MCA filings.

The compliance status of Nulife Advanced Diagnostics is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.